Discusses Strategic Focus on Izicopan for ANCA-Associated Vasculitis and Renal Diseases May 8, 2026 8:30 AM EDTCompany ...
CLYM116 modeling and initial Phase 1 safety data to be presented at ERA 2026 with initial Phase 1 PK/PD data expected mid-2026 Budoprutug pMN, ITP, and SLE clinical trials enrolling to plan; ...
Discusses BGE-102 Clinical Results and Development Strategy for Cardiovascular and Retinal Disease May 8, 2026 12:30 PM ...
MarketBeat on MSN
InflaRx investor update: Izicopan set to take center stage in AAV and renal disease pipeline
InflaRx (NASDAQ:IFRX) outlined plans to prioritize development of izicopan, an oral inhibitor of the C5a receptor (C5aR), in ...
Hosted on MSN
IBM, Riken, Cleveland Clinic link quantum and supercomputers for record protein simulation
Record-setting scale: Researchers simulated protein-ligand complexes up to 12,635 atoms, the largest hybrid quantum-classical chemistry calculation for a biologically relevant system. Hybrid workflow: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results